As of 2024-12-13, the Intrinsic Value of West Pharmaceutical Services Inc (WST) is
311.12 USD. This WST valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 331.62 USD, the upside of West Pharmaceutical Services Inc is
-6.20%.
The range of the Intrinsic Value is 201.41 - 753.29 USD
311.12 USD
Intrinsic Value
WST Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
201.41 - 753.29 |
311.12 |
-6.2% |
| DCF (Growth 10y) |
245.75 - 868.36 |
370.36 |
11.7% |
| DCF (EBITDA 5y) |
235.86 - 362.84 |
306.45 |
-7.6% |
| DCF (EBITDA 10y) |
273.39 - 435.48 |
357.37 |
7.8% |
| Fair Value |
172.47 - 172.47 |
172.47 |
-47.99% |
| P/E |
261.87 - 339.55 |
310.60 |
-6.3% |
| EV/EBITDA |
140.23 - 330.83 |
250.56 |
-24.4% |
| EPV |
80.55 - 109.05 |
94.80 |
-71.4% |
| DDM - Stable |
81.92 - 420.29 |
251.11 |
-24.3% |
| DDM - Multi |
165.86 - 655.49 |
264.03 |
-20.4% |
WST Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
24,015.92 |
| Beta |
0.77 |
| Outstanding shares (mil) |
72.42 |
| Enterprise Value (mil) |
23,730.72 |
| Market risk premium |
4.60% |
| Cost of Equity |
7.69% |
| Cost of Debt |
4.25% |
| WACC |
7.65% |